We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen.
Journal of Biological Chemistry 1982 June 11
To examine the possibility that Factor XIII zymogens bind to fibrinogen, we have studied the reaction between radiolabeled Factor XIII and fibrinogen coupled to beads. Platelet and plasma Factor XIII were iodinated with Na(125I)iodide using lactoperoxidase. Both forms of 125I-Factor XIII retained greater than 92% of the transglutaminase activity. 125I-platelet and plasma Factor XIII specifically bound to human fibrinogen covalently coupled to either carboxylated latex or acrylonitrile beads but not to fetuin- or albumin-coated beads. Unlabeled platelet Factor XIII inhibited 90% of the total binding of 125I-platelet and 125I-plasma Factor XIII to fibrinogen, whereas human IgG, fetuin, and serum albumin had no effect. These data suggest that 125I-platelet and plasma Factor XIII specifically bind to fibrinogen by the a2 subunit. 125I-Factor XIII which was bound to the fibrinogen beads migrated identically to unbound material on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Soluble fibrinogen inhibited binding of 125I-Factor XIII to fibrinogen beads, indicating that binding is not due to alteration of the fibrinogen coupled to the beads. Binding of 125I-Factor XIII was reversible and time- and temperature-dependent: maximal binding occurred by 1 min at 37 degrees C. Binding was independent of calcium; 10 mM EDTA had no effect. Binding was dependent on sodium chloride concentration; complete inhibition of binding occurred at concentrations above 300 mM NaCl. The Kd for binding, 1 X 10(-8) M, is approximately 7-fold higher than the concentration of Factor XIII in plasma. These data support the hypothesis that Factor XIII circulates in plasma bound to fibrinogen. This interaction may play a role in regulating the physiologic activation and function of Factor XIII.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app